Clinical Trial Update: Ablative Radiotherapy to Restrain Every Metastasis Safely Treatable (ARREST-2): A Randomized Phase II/III Trial [NA]

View source ↗

Summary

ARREST-2 is an ongoing randomized Phase II/III trial, currently recruiting, evaluating ablative radiotherapy to safely target and restrain every metastasis in p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Metastatic Cancer | NA | Status: RECRUITING